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Abstract
Background
The World Health Organization recommends that schistosomiasis be treated through Mass
Drug Administration (MDA). In line with this recommendation, Zimbabwe commenced a
national helminth control program in 2012 targeting schoolchildren throughout the country
for 6 years. This study, part of a larger investigation of the impact of helminth treatment on
the overall health of the children, determined the effect of annual praziquantel treatment on
schistosome infection and morbidity in a cohort of children during Zimbabwe’s 6-year
national helminth control program.
Methodology/Principal findings
A school-based longitudinal study was carried out in 35 sentinel sites across Zimbabwe
from September 2012 to November 2017. The sentinel sites were selected following a coun-
trywide survey conducted in 280 primary schools. Schistosoma haematobium was diag-
nosed using the urine filtration technique. Schistosoma mansoni was diagnosed using both
the Kato-Katz and formol-ether concentration techniques. S. haematobium morbidity was
determined through detection of macro and microhaematuria. A cohort of children aged
6–15 years old was surveyed annually before MDA and 6 weeks post treatment. Maximum
treatment coverage reached 90% over the 6 rounds of MDA. At baseline S. haematobium
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infection prevalence and intensity were 31.7% (95% CI = 31.1–32.2) and 28.75 eggs/10ml
urine (SEM = 0.81) respectively, while S. mansoni prevalence and intensity were 4.6%
(95% CI = 4.4–4.8) and 0.28 eggs/25mg (SEM = 0.02). Prior to the 6th round of MDA, S. hae-
matobium infection prevalence had reduced to 1.56% (p<0.001) and infection intensity to
0.07 (SEM 0.02). Six weeks later after the 6th MDA, both were 0. Similarly the prevalence of
S. haematobium morbidity as indicated by haematuria also fell significantly from 32.3%
(95% CI = 29.9–34.6) to 0% (p< 0.0001) prior to the final MDA. For S.mansoni, both preva-
lence and intensity had decreased to 0 prior to the 6th MDA. After 6 rounds of annual MDA,
prevalence and intensity of both schistosome species decreased significantly to 0% (p<
0.0001).
Conclusion
Zimbabwe’s helminth control program significantly reduced schistosome infection intensity
and prevalence and urogenital schistosomiasis morbidity prevalence in a cohort of school-
aged children, moving the schistosome prevalence in the children from moderate to low by
WHO classification. These findings will inform the design of the country’s next stage inter-
ventions for helminth control and eventual elimination.
Author summary
Following a national helminth prevalence survey conducted in 2010/2011, Zimbabwe
launched a national schistosomiasis and intestinal worm control program in 2012 targeting
school children aged 6–15 years who carry the highest infection burden. The control strat-
egy as advocated by the World Health Assembly in 2012 was adopted to suit the country
context. We conducted a study in a cohort of children to assess the effect of praziquantel
treatment on schistosome infection intensity and prevalence as well as on urogenital schis-
tosomiasis morbidity prevalence after every annual MDA for 6 years. Maximum treatment
coverage in a cohort of children reached 90% over the 6 rounds of annual treatment.
Annual surveys in sentinel sites throughout the country showed that schistosome infection
prevalence and intensity as well as the marker of urogenital schistosomiasis, haematuria
decreased significantly after each round of treatment from the pre-treatment levels in the
same year. Most notably, both urogenital schistosomiasis infection and morbidity preva-
lence reduced from 32% at baseline in 2012 to 1.56% before the 6th MDA in 2017, and
infection intensity reduced from 28.75 eggs/10ml urine to a mean of 0.07eggs/10ml urine
prior to the 6th MDA. Both infection prevalence and intensity fell to 0 after the 6th MDA.
Intestinal schistosomiasis prevalence and intensity reduced from 4.6% and 0.28 eggs/25mg
of stool to 0% and 0 eggs, respectively. Thus, the control program significantly reduced
schistosome infection and morbidity in this cohort of schoolchildren.
Introduction
Zimbabwe is endemic to several of the neglected tropical diseases (NTDs) as listed by the
World Health Organization (WHO) [1]. Of these NTDs, schistosomiasis is the most prevalent
in the country. Both forms of schistosomiasis; urogenital and intestinal, occur in Zimbabwe
with the former being more prevalent [2]. From the very first community survey in Zimbabwe,
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then Rhodesia, in 1932 [3], Zimbabwe has had programs to control schistosomiasis [4]. These
programs have targeted workers and schoolchildren using several approaches including treat-
ment of infected people (first with tartar emetic and then praziquantel(PZQ)), improving
water and sanitation, snail control and education/awareness campaigns [4]. However, these
programs have mostly been focal in space and time [5–8]. In 2012 the WHO set out a roadmap
for NTDs, including controlling schistosomiasis morbidity by 2020 and elimination of schisto-
somiasis as a public health problem and interrupting transmission in various African countries
by 2025 [9]. As part of implementing this roadmap, Zimbabwe has been conducting a national
helminth control program targeting school children aged 6 to 15 years, whom previous studies
in the country have shown to carry the heaviest burden of schistosome infection in Zimbabwe
[8, 10–13].
To inform the national control program, we performed a nationwide school-based survey
in 2010/2011, mapping S. mansoni, S. haematobium, and the soil-transmitted helminth species:
Ascaris lumbricoides, Trichuris trichiura and hookworm [2]. This was done by collecting data
at district level, and thereby representative of the corresponding provinces. Data from this
study revealed high schistosomiasis prevalence in 55 districts and soil transmitted helminths
occurring in 47 districts, with 33 districts being endemic to both types of NTDs. The nation-
wide combined prevalence of schistosomiasis was 22.7% while that for STH was 5.5% [2].
These levels of infection demanded urgent interventions. Following this, the Ministry of
Health formulated a national NTD control policy, an initial 5-year action plan and imple-
mented school-based mass drug administration (MDA) targeting primary and secondary
school children across the country [4]. Crucially, Zimbabwe’s control program treated all chil-
dren annually irrespective of the regional prevalence of infection. This is in contrast to the
WHO preventive chemotherapy guidelines that recommend the frequency of treatment based
on community/regional infection level, i.e. high risk communities, those with a prevalence of
50% and over, should be treated annually, whereas those at lower risk should be treated every
two years (over 10% but less than 50%). In cases where prevalence was less than 10%, then the
recommendation is that children should be treated twice within their school career [14] [15].
While data on the coverage of the country’s helminth control program has been docu-
mented (see http://espen.afro.who.int/countries/zimbabwe), there had been no indication of
the effectiveness of the control program in terms of efficacy of praziquantel treatment on infec-
tion intensity and prevalence as well as on levels of urogenital schistosomiasis morbidity as
measured by haematuria. This study is part of an investigation on the impact of schistosomia-
sis treatment with PZQ during the national control program on overall human health includ-
ing morbidity markers, inflammatory markers, allergic responses and autoreactivity in school
children. For this study, we determined egg reduction rates (ERR) and cure rates (CR) in a
cohort of school children. This current study focuses on the effect of annual PZQ treatment on
schistosome infection intensity and prevalence and urogenital schistosomiasis morbidity in
this cohort of school children during Zimbabwe’s national helminth control program and
compares infection levels from the start of the MDA to our last survey six weeks after the 6th
round of MDA.
Materials and methods
Ethical approval and consent
The study received institutional approval from the University of Zimbabwe and Ethical
approval from the Medical Research Council of Zimbabwe MRCZ/A/1710. Permission to con-
duct the study in the provinces was obtained from the Ministry of Health & Child Care.
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Recruitment into the study was voluntary and parents/guardians gave written parental consent
and were free to withdraw the participants at any time with no further obligation.
Background and national MDA
Between September 2010 and August 2011, a national schistosomiasis and soil transmitted hel-
minths survey was conducted in Zimbabwe by the Ministry of Health and Child Welfare
through the Epidemiology and Disease Control Department and National Institute of Health
Research with support from the Ministry of Education, the WHO and UNICEF [2].
In keeping with the observation that school children constitute the high-risk age group for
schistosomiasis and STH in the community [14], the survey was conducted in school children
aged 10–15 years old. The survey was a countrywide cross-sectional survey carried out by sam-
pling 50 children in each of 280 primary schools in all the 68 districts of the country’s total
eight provinces. The national survey indicated the different districts in the country which fell
in the WHO classification of heavy, moderate and low schistosome endemicity based on the
infection levels in the school children [15].
Following this national survey, annual MDAs were carried out in September 2012, October
2013, January 2015, November 2015, November 2016 and November 2017. The third MDA
was delayed due to logistical reasons, resulting in the reduced gap between the third and fourth
MDA being less than 12 months. The children in the cohort study described here were treated
during these MDAs.
Study design
The study presented here was designed to follow a cohort of primary school children who
were targeted by this MDA from September 2012 to November 2017. Sites throughout the
country were purposely chosen before the commencement of the MDA program to represent
the 3 levels of schistosomiasis infection prevalence as described by WHO i.e. low, moderate
and high [14] at both district and province level as shown in Fig 1. The sentinel sites were also
chosen to represent the baseline prevalence classification of the district (low, medium or high)
(see S1 Fig). In total 35 schools located in 29 districts and 8 provinces were included in the
study. The sample sizes are given in Table 1 and the map of the 8 provinces is given in Fig 2A.
Of the 8 provinces, 6 had at least one sentinel site included in every MDA, while 2 provinces
were not included in all the surveys. Matabeleland South and Mashonaland West were not sur-
veyed in all MDAs. The national survey showed that Matabeleland South had the lowest schis-
tosomiasis prevalence in the country [2] and it was deemed not cost effective to survey this
province after every MDA. Therefore, this province was surveyed at the start of this project in
2012 and at the end in 2017, i.e. pre- and post-MDA 1 and post-MDA 6. Similarly other sites
including all those in Mashonaland West were sampled at the start-point (MDA1), mid-point
(MDA4) and end-point (MDA6) of the control program. These are detailed in S1 Fig and in
Table 1. In the remaining sentinel sites children were surveyed annually for the duration of
the study.
For each MDA, the school children were sampled at two points, prior to treatment (pre-
MDA) and 6 weeks after treatment was given (post-MDA). Twelve schools (sentinel sites;
Gonye, Siabuwa, Muzarabani, Kafura, Chiguri, Mukwakwe, Negato, Mareya, Ruzongwe,
Mbembi, Bandanyenje, Kanyaga) (see Fig 2B) were followed up annually. As indicated in the
study design in Fig 1, these 12 schools were purposely selected to represent the full range of
the different levels of baseline schistosomiasis infection prevalence i.e. low, moderate and high.
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Study population
The study recruited children aged 6–15 years old and these children would typically be in
grades 3–7 in primary school. The children were randomly selected prior to the start of the
study in 2012 and the same children were followed up for the duration of the study i.e. until
2017. The selected children were sampled at each sampling point regardless of whether they
had received treatment in the last MDA or not. The treatment records of the children were
extracted during the post-MDA visit for each MDA, from the MDA records kept by the school.
These records informed the treatment coverage rates. Children leave primary school in Zimba-
bwe for senior school after grade 7, therefore, children who moved out of grade 7 were fol-
lowed up if enrolled at a local secondary school to ensure the post treatment follow-up. The
majority of children lost to follow-up were those who had completed primary school and
moved on to secondary school as well as those who transferred to other distant schools.
Inclusion criteria
To be included in the study, children had to i) provide all 2 stool samples and 3 urine samples
for schistosome parasitology and morbidity determination at pre-treatment and 6 weeks post-
treatment survey points, ii) have been offered treatment with PZQ during that year’s MDA.
Study sample sizes
Our national survey sampled 50 children from each school based on the sample size calcula-
tion previously published which gave a total sample size of 15, 818 [2] for the national survey.
Fig 1. Study design. The schistosome endemicity levels (low, medium, high) were stratified based on combined S. mansoni and S. haematobium infection prevalence.
https://doi.org/10.1371/journal.pntd.0008388.g001
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Briefly, in that national survey calculation using 37% as the assumed mean prevalence of schis-
tosomiasis and the error margin of 0.75%, the number of schools selected per district was
determined by dividing the district sample size calculated proportionally from the national
sample size by the number of children that would be screened per school (n = 50). In this sur-
vey, we based our study design on that original study design for consistency and our sample
sizes were informed by the original countrywide survey. The present study was to follow the
children for 6 years, we were cognizant of the possibility of loss due to migration. Thus, using
the national sample size calculation we aimed to recruit a sample size of 250 children per
school, with a minimum school sample size of 150 to give a total of 8750 children which would
be 55% of the number of children sampled in the national survey. At baseline, a total of 8015
Table 1. Summary study sample sizes by MDA.
Province District School Total number of surveys Number of children surveyed per MDA
1 2 3 4 5 6
Manicaland Bikita Chitenderano 2 195 - - - - 195
Manicaland Buhera Masocha 6 242 - - 242 - 242
Manicaland Chipinge Chitepo 6 250 - - 250 - 250
Manicaland Makoni Bandanyenje 12 242 242 211 242 242 193
Manicaland Nyanga Chipataronga 6 398 - - 398 - 398
Mashonaland Central Guruve Nyanhunzi 6 179 - - 179 - 179
Mashonaland Central Mazowe Mbebi 6 186 - - 186 - 186
Mashonaland Central Mt Darwin Bemberi 12 201 206 206 222 196 145
Mashonaland Central Muzarabani Muzarabani 12 298 297 298 298 298 213
Mashonaland Central Rushinga Mazowe Valley 12 250 250 250 250 250 208
Mashonaland Central Shamva Chihuri 6 218 - - 218 - 218
Mashonaland Central Shamva Gono 3 200 - - - - 200
Mashonaland East Chikomba Nhidza 6 250 - - 250 - 250
Mashonaland East Murewa Chiguri 12 198 198 198 198 198 175
Mashonaland East Murewa Chingono 6 224 - - 224 - 224
Mashonaland East Mutoko Chimukopa 12 250 198 224 224 224 201
Mashonaland East Mutoko Kushinga 6 198 - - 198 - 198
Mashonaland East UMP Kafura 12 250 250 250 250 250 226
Mashonaland West Chegutu Gadzema 6 267 - - 267 - 267
Mashonaland West Hurungwe Dandawa 6 206 - - 206 - 206
Mashonaland West Hurungwe Gache-gache 6 233 - - 233 - 233
Mashonaland West Makonde Kanyanga 6 250 - - 249 - 249
Mashonaland West Zvimba Chomutamba 3 247 - - - - 247
Masvingo Chiredzi Mareya 12 220 218 218 218 218 200
Masvingo Gutu Mutendeure 3 192 - - - - 192
Masvingo Mwenezi Rudzongwe 12 267 267 267 267 267 210
Matabeleland North Binga Siabuwa 3 233 - - - - 233
Matabeleland North Nkayi Gonye 12 242 242 211 242 242 193
Matabeleland North Insiza Insiza 3 248 - - - - 240
Midlands Chirumanzu Gambiza 3 123 - - - - 123
Midlands Gokwe North Chireya 3 192 - - - - 192
Midlands Mberengwa Mukwakwe 12 177 179 160 179 179 156
Midlands Mberengwa Nhemga 3 250 - - - - 248
Midlands Mberengwa Zverenje 3 253 - - - - 253
Midlands Shurugwi New Gato 12 186 186 186 186 186 186
https://doi.org/10.1371/journal.pntd.0008388.t001
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children satisfied the eligibility criteria. Of these children, 7529 (94%) were followed up at the
last survey after MDA 6. Of the children from the 12 sentinel sites followed every year, 2781
children were recruited, with 2306 (83%) followed up. Annual sample sizes are summarised in
Table 1. Overall there was a loss to follow-up of 6% from MDA1 to MDA6.
Parasitology
Stool and urine samples were collected from each child between 1000 and 1400 hours, the
period when peak egg excretion is expected [16], S. mansoni infection status and intensity
were determined by microscopic examination of slides prepared using the Kato-Katz tech-
nique [17] and the formol-ether concentration technique [18] for collecting parasite eggs from
stool samples. Two stool samples were collected from each individual over two consecutive
days. A single slide was prepared following the Kato-Katz procedure using the 41.7mg tem-
plate from each stool sample. The egg count from the 41.7mg template was multiplied by 24 as
per WHO protocol guidelines (https://www.who.int/medical_devices/diagnostics/selection_
in-vitro/selection_in-vitro-meetings/00054_01_kato-katzBench_aids.pdf). The participant’s
egg count was the arithmetic mean calculated from the two slides and recoded as the mean
eggs per gram of stool. Stool left over from one stool sample was used for the formol-ether con-
centration technique [18]. There were no indicators for S. mansoni morbidity assessed due to
lack of a point of care rapid diagnostic.
For S. haematobium infection status and intensity, a urine sample was collected from each
participant on three consecutive days. 10mls of this urine was processed following the urine fil-
tration method [19]. Thus, from each participant the three slides were prepared one from each
day. The individual’s egg count was the arithmetic mean calculated from the three slides. S.
haematobium morbidity was determined by detection of blood in urine using dipsticks, pres-
ence of blood in urine in S. haematobium endemic areas is also used as indicative of S. haema-
tobium infection [20]. Individuals were only considered positive if schistosome eggs were
detected in their urine/stool samples.
Antihelminthic treatment
As previously indicated, the treatment was administered by the National Helminth Control
treatment team as part of the annual national helminth MDA program. Children were mea-
sured using the PZQ dose poles to determine treatment dose and regardless of infection status,
were co-administered a standard dose of PZQ i.e. 40mg/kg and albendazole at 400mg per
child. During treatment, children were checked to confirm they had swallowed the tablet, and
were given bread and juice. Treatment was administered by nurses and the school health coor-
dinators, as is the Ministry of Health practice in Zimbabwe for the national helminth control
program. The number and type of tablets administered was recorded for each child in MDA
registers, for accurate recording of the MDA reach as well as to distinguish non-compliance
from treatment failure in subsequent follow-ups.
Treatment coverage data
Summary treatment coverage data were available at program level for the country’s MDA pro-
gram annually for the duration of the study. In 2017, these data were present at district level
Fig 2. Maps showing sentinel sites at different administration levels. The maps were generated using GIS raw data for the
schools using ArcMap 10.1. Sentinel sites are italicized and the number of MDA surveys indicated. A. Map showing sentinel sites
at province level. B. Maps showing sentinel sites at different administration levels. The maps were generated using GIS raw data
for the schools using ArcMap 10.1. Map showing sentinel sites at district level.
https://doi.org/10.1371/journal.pntd.0008388.g002
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and the findings of the study were related to these data. All children followed up in the study
were confirmed to have received PZQ treatment at each MDA.
Statistical analysis
Data recorded on field sheets was double entered and proof read in an Excel spreadsheet and
comprised data from MDA 1 to 6 with both pre-MDA and post-MDA data recorded for each
individual. Infection prevalence and intensity for each time point was calculated for each
district.
To determine the effect of treatment on infection level, the ERR, a measure of the change in
parasite egg burden upon treatment, and the CR, a measure of those cured of infection upon
treatment, were calculated using data from treated children (as confirmed by the school MDA
registers) who were positive for schistosome infection using Eqs 1–4 below.
Infection intensity ¼
Arithmetic Mean egg count for all individuals
Total number of individuals sampled
Eq 1
Prevalence ¼
Number of individuals positive for infection
Total number of individuals sampled
� �
x 100 Eq 2
ERR %ð Þ ¼ 1  
Arithemtic mean infection intensity following Rx
Arithmetic mean infection intesity in infected people at baseline
� �� �
x100Eq 3
CR ð%Þ ¼
Number of individuals positive at baseline and negative following RX
No of individuals positive at baseline
� �
x100Eq 4
where: ERR = egg reduction rate, CR = cure rate, RX = treatment.
Prevalence data and infection intensities were analysed using Minitab Statistical Software
18 and GraphPad Prism 8. Due to the non-parametric nature of the data, differences in preva-
lence between annual MDAs were tested for significance using a Fisher’s exact test, whereas
difference between pre- and post-MDA time points were analysed using a paired McNemar’s
test [21]. Infection intensities between annual MDAs were tested using an unpaired Student’s
t-test following Log10 (X+1) transformation to normalise data, and between pre- and post-
MDA a paired two-way Student’s t-test was calculated. For all analyses, a value of p<0.05 was
considered significant. Infection prevalence maps were generated using this primary raw data
and plotted using the software package ArcMap 10.1.
Results
Effect of treatment in the school children cohort at national level
Prior to the MDA, Schistosoma haematobium prevalence in the sentinel sites was 31.7% and,
consistent with Zimbabwe’s 2010 national schistosomiasis survey. S. haematobium was the
most prevalent schistosome species in the country [2]. Following 6 annual rounds of MDA,
the prevalence of S. haematobium decreased significantly to 0% (p<0.0001) (Fig 3A). When
comparing infection prevalence pre-treatment, the pre-MDA 1 prevalence of 31.7% decreased
to 1.56% (p<0.001) at pre-MDA 6 i.e. 12 months after the last MDA allowing for a full reinfec-
tion cycle (Fig 3A).
Schistosoma mansoni was tested for using both the Kato-Katz and formol-ether technique,
and the prevalence resulting from each at baseline was found to be 4.6% and 1.4% respectively.
The results of the more widely used Kato-Katz diagnostic are shown in Fig 3B. After the last
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MDA in 2017, S. mansoni prevalence was 0% when tested by both diagnostic techniques
(p<0.0001). When comparing infection prevalence pre-treatment, the pre-MDA 1 prevalence
of 4.6% by Kato-Katz decreased to 0% (p<0.0001) at pre-MDA 6 and from 1.4% at pre-MDA
1 by formol-ether also to 0% at pre-MDA 6 (see Fig 3B for the Kato-Katz data).
For both causative species of human schistosomiasis in Zimbabwe, S. haematobium and S.
mansoni, arithmetic mean infection intensity (analysed using the Log10(mean egg count+1)
transformation) in the cohort of school children decreased significantly from the initiation of
the MDA programme to the end (p =<0.0001) (see Fig 4). S. haematobium decreased from a
mean of 0.49 (SEM = 0.01) to 0.07 (SEM 0.02) at pre-MDA 6 (see Fig 4A) and 0 (SEM = 0) at
post-MDA 6. S. mansoni infection intensity determined by Kato-Katz decreased from 0.03
(SEM = 0.002) at pre-MDA 1 to 0 (SEM = 0) at both pre- and post-MDA 6, and from 0.006
(SEM = 0.0007) at pre-MDA 1 to 0 (SEM = 0) again at both pre- and post-MDA 6 using the
formol-ether diagnostic technique (4b).
Schistosome morbidity
Macro or visible haematuria measured as a marker of morbidity of S. haematobium infection
fell significantly from 32.3% in pre-MDA 1 to 0% at post-MDA 6 (p<0.001) and the gradual
decline is shown in Fig 5. The prevalence of haematuria had fallen to 0% prior to the 6th MDA.
Effect of treatment in the school cohort at province level
The impact of treatment was investigated in all 8 provinces. The study shows that the first
MDA had a significant effect on infection levels. Investigations in the sentinel sites in the 6
provinces surveyed at every MDA for the 6 MDAs shows a gradual decline in infection level.
Fig 6A shows the decline in S. haematobium infection prevalence while Fig 6B shows the
decline in S. mansoni prevalence as assessed by Kato-Katz.
Matabeleland North started with a prevalence of 5.3% for S. haematobium and 1.5% for
S. mansoni in 2012 and decreased in both species to 0% by 2017. Masvingo had the highest
starting prevalence among the provinces, calculated at 51.9% for S. haematobium and 16.1%
for S. mansoni in 2012. These both decreased to 0% following the last MDA in 2017. The
prevalence of S. haematobium in the Midlands was 32.3% in 2012 decreasing to 0% in 2017
and S. mansoni prevalence in the Midlands started at 0% in 2012, and remained at 0% in
2017. Mashonaland West province had a prevalence of 18.1% for S. haematobium and 2.1%
in S. mansoni in 2012, both of which decreased to 0% in 2017. Mashonaland Central had a
prevalence of 36.4% for S. haematobium and 3.7% for S. mansoni in 2012, and again, both
decreased to 0% in 2017. Mashonaland East had an initial prevalence of 30.4% for S. haema-
tobium and 3.9% for S. mansoni. These decreased to 0% after the 6th MDA. Manicaland
province had a prevalence of 35.6% for S. haematobium and 8.8% for S. mansoni before the
first MDA, and both decreased to 0% after the last MDA. Overall, the final data collected
following the 2017 annual MDA revealed that every province had decreased to 0% for both
S. haematobium and S. mansoni.
The overall change in prevalence between pre-MDA 1 and post-MDA 6 was significant in
both S. haematobium (p =<0.0001) and S. mansoni (p =<0.0001) (Fig 2). When investigating
this at a province level, the difference in prevalence of S. haematobium was significant for
Fig 3. Decline in overall infection prevalence in the cohort of children during the MDAs. Red bars = pre-treatment
infection prevalence for each MDA. Blue bars = post-treatment infection prevalence for each MDA. A. S.
haematobium. B. S. mansoni as diagnosed through the Kato-Katz procedure during the MDAs. Red bars = pre
treatment infection prevalence for each MDA.
https://doi.org/10.1371/journal.pntd.0008388.g003
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Mashonaland West, East, Central, Midlands, Masvingo, Manicaland (all p =<0.0001) and
Matabeleland North (p = 0.0002). The change in prevalence of S. mansoni on the province
level was also significant in Mashonaland East, West, Central, Manicaland and Masvingo (all p
=<0.0001), however Matabeleland North was not (p = 0.2000) and Midlands had no detect-
able S. mansoni at either time points. The impact of the MDAs on both schistosome species is
shown in S2 Fig.
Effect of treatment in the school cohort at district level
Of the 29 districts investigated in MDA 1, 24 (82.8%) districts were positive for S. haemato-
bium, 33.3% for both and 10 (34.5%) districts were positive for S. mansoni. District prevalences
ranged from 0% to 88.1% pre-MDA 1 for S. haematobium and 0% to 25.5% for S. mansoni as
shown by the data of pre-MDA 1 prevalences in Fig 6A for S. haematobium and Fig 6B for S.
mansoni. Infection prevalence in all districts was 0% post-MDA 6 for both species.
The summary of the overall impact on national prevalence in the cohort of children, pre-
senting the initial data collected prior to the commencement of the first MDA in 2012, to the
final measurements taken following the 6th MDA in 2017 is shown in Fig 7.
Egg reduction and cure rates
The egg reduction rates (ERR) and cure rates (CR) were calculated for each MDA. Overall
ERR and CR are given in Tables 2 and 3 respectively. Across all provinces, for both S. mansoni
and S. haematobium, ERR were all above 90%. Across the MDAs, average CR ranged from
83.4% to 100% for S. haematobium and 92.8% to 100% for S. mansoni diagnosed by Kato-Katz
and 95.8% to 100% for S. mansoni diagnosed by formol-ether technique.
Fig 4. Decline in overall S. haematobium infection intensity during the MDAs in the cohort of children. Red bars = pre-
treatment infection intensity for each MDA. Blue bars = post treatment infection intensity for each MDA. A. S.
haematobium, B. S. mansoni infection intensity as measured by Kato-Katz.
https://doi.org/10.1371/journal.pntd.0008388.g004
Fig 5. Decline in the prevalence of S. haematobium morbidity as measured by visible haematuria in the cohort of children.
https://doi.org/10.1371/journal.pntd.0008388.g005
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Fig 6. Decline in infection prevalence at province level during the MDAs. A. S. haematobium. B. S. mansoni as measured by Kato-Katz in the
cohort of children.
https://doi.org/10.1371/journal.pntd.0008388.g006
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Treatment coverage
Mean coverage across all the provinces was lowest in MDA 1 at 48%, but this increased gradu-
ally peaking at 90.3% in the cohort during MDA 5 (Fig 8). While the mean national coverage
Fig 7. Changes in prevalence at national level in the cohort of children. A. S. haematobium. B. S. mansoni. The maps were generated using GIS raw data for
the schools using ArcMap 10.1.
https://doi.org/10.1371/journal.pntd.0008388.g007
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at MDA 6 was 82.3% there was heterogeneity between districts with coverage ranging from
73.5% (Mashonaland West) to 96.5% (Mashonaland Central) for MDA 6 (S3 Fig).
Discussion
The Uniting to Combat NTDs score card calculates Zimbabwe’s efforts to combat NTDs in
terms of average of coverage across the five diseases amenable to mass treatment (schistosomi-
asis, soil transmitted helminths (STH), river blindness, trachoma, elephantitis) as 12% but
indicates that the coverage for schistosomiasis is 100% (see https://unitingtocombatntds.org/
africa/zimbabwe/). However, these score card data do not indicate the effectiveness of the
country’s helminth control program in terms of reducing infection level or morbidity. This
study presents the results from the analysis of the effect of annual praziquantel treatment on
schistosome infection and morbidity in a cohort of primary school children during the
national helminth control program in Zimbabwe. The study showed that upon sustained
annual MDA using PZQ to treat schistosome infections and morbidity, both schistosome
infection and morbidity have been significantly reduced in this cohort of children, meeting the
WHO aim of reducing morbidity and infection in school-aged children [22].
Zimbabwe adopted a country strategy to treat all affected areas annually for 6 years. By sur-
veying sentinel sites before the MDA and 6 weeks after the MDA every year, we have been able
to demonstrate that following the third MDA, the prevalence of schistosomiasis in the cohort
of school children in every province fell under the low-risk category deemed by the WHO i.e.
prevalence of less than 10% [14][15] and remained there consistently throughout the rest of
the programme.
Zimbabwe is one of the 41 African countries mentioned in the latest WHO Report on
NTDs [23], as currently having preventive chemotherapy programs for schistosomiasis. Of
these countries 28 (68.3%) which include Zimbabwe, were implementing preventative
Table 2. Mean egg reduction rate (%).
MDA S. haematobium S. mansoni (Kato-Katz) S. mansoni (Formol-Ether)
1 99.29 95.72 98.58
2 91.16 N/A 100
3 96.99 100 N/A
4 100 100 N/A
5 97.77 100 N/A
6 100 N/A N/A
N/A represents MDA where the pre-treatment infection intensity was 0 eggs/ml or 0 eggs/mg.
https://doi.org/10.1371/journal.pntd.0008388.t002
Table 3. Mean cure rates (%).
MDA S. haematobium S. mansoni (Kato-Katz) S. mansoni (Formol-Ether)
1 93.98 92.83 95.83
2 84.84 100.00 100.00
3 83.39 N/A N/A
4 100.00 100.00 N/A
5 100.00 100.00 100.00
6 100.00 N/A N/A
N/A represents MDA where the pre-treatment infection intensity was 0 eggs/ml or 0 eggs/mg.
https://doi.org/10.1371/journal.pntd.0008388.t003
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chemotherapy programs in 2015. Of these only 15 had extended coverage to all endemic areas.
In addition to this annual treatment across all levels of schistosome endemicity, the treatment
coverage obtained each year generally increased from MDA 1 throughout the program. Maxi-
mum coverage reached for all school children targeted in Zimbabwe’s helminth control pro-
gram which included the cohort of children in this study, was 90%. This was above the
recommended 75% coverage of school-aged children as detailed in the “2020 roadmap” set out
by the WHO [9].
While there was an overall reduction in infection prevalence and intensity over the duration
of the control program in the cohort of school children, there was some rebound in infection
particularly over the first 3 years. This is unsurprising as there were no control efforts directed
at breaking the transmission cycle. Studies in Kenya indicate that the reinfection can be suffi-
ciently intense as to warrant more than an annual treatment [24]. In Zimbabwe, with increas-
ing treatment coverage came lower re-infection rates culminating in the reduction of
prevalence to 0% in this cohort of school children following the last MDA.
For both S. mansoni and S. haematobium, ERR were above 90%. Across the MDAs, average
CR ranged from 83.4% to 100% for S. haematobium and 92.8% to 100% for S. mansoni diag-
nosed by Kato-Katz and 95.8% to 100% for S. mansoni diagnosed by formol-ether technique.
Variations in treatment outcome have been previously reported and have prompted studies
into trying to identify better measures of PZQ efficacy since parasite egg excretion is only a
proxy for drug effects on adult worms [25]. Egg excretion can be confounded by various host
or parasite factors, including facultative temporary cessation of excretion by the adult worms
[25]. Variation in both CR and ERR measures could be attributable to parasite- or host-based
factors including varying efficacy of PZQ in the killing of S. haematobium and S. mansoni in
co-endemic areas [26], the intensity of the initial infection, host genetics, and the sensitivity of
the diagnostic tests used to identify either species. For example, the urine filtration technique
and Kato-Katz technique can miss low-level infections [27]. In areas with a particularly high
prevalence of schistosomiasis, there is a greater chance of individuals being infected with
immature schistosomes at the time of MDA treatment and therefore will not be completely
cleared by one dose of praziquantel [28]. Furthermore, in areas of high transmission, high lev-
els of reinfection can occur especially if the MDA occurs before the transmission period.
Fig 8. Relationship between treatment coverage rates and schistosome infection prevalence across the MDAs in the cohort of
children.
https://doi.org/10.1371/journal.pntd.0008388.g008
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Treatment of only school children excluding adults and preschool children potentially main-
tains transmission. All of these factors may explain the observed persistence of infection post-
treatment, such as that of Mashonaland Central in both Schistosoma species, for the first 3
MDAs in this study [29, 30].
The possibility of the parasites developing resistance to PZQ is always a present threat, with
reports of low CR in certain regions [31, 32]. Indeed reduced efficacy of PZQ has been
reported following multiple rounds of MDA in Uganda for S. mansoni [33]. To counteract
these fears, investigations into multiple cases of laboratory and field PZQ resistance deter-
mined that the reduced efficacy of drug treatment due to resistance was rare [34]. Further-
more, a meta-analysis of PZQ CR and ERR we have conducted indicates that these have not
changed significantly in the past 20 years. The reduction of infection at the sentinel sites to 0%
and 0 egg counts for both schistosome species reflects that treatment remained efficacious
throughout the MDA period. As Zimbabwe intensifies control efforts to move towards elimi-
nating schistosomiasis as a public health problem, it will be important to collect parasite sam-
ples from infection hot spots to determine causes of persistent infection [35].
While Zimbabwe has made significant progress towards the control of schistosomiasis
through this 6-year MDA program, more still needs to be done; first to maintain the low infec-
tions achieved in the primary school children who were the target of Zimbabwe’s helminth
control program represented by the cohort of children studied here and, second to include all
populations at risk of infection i.e. adults and preschool children. The 2012 World Health
Assembly resolution 65.21 advocates for elimination of schistosomiasis transmission in mem-
ber states. This is an aspirational goal for Zimbabwe although in practise a difficult task.
Annual MDA is not sustainable long-term for most endemic countries both for economic and
logistical reasons in health systems with low budgets. It is also not effective on its own, at meet-
ing the elimination aspiration of WHA 65.21. Thus, Zimbabwe, similar to all other schisto-
some endemic countries aiming to eliminate the disease, needs to strengthen concerted efforts
to both reduce infection and morbidity, and also interrupt transmission. This must be based
on integrated control approaches including intense PZQ treatment targeted at any hot spots of
infection/transmission, snail control, treatment of infective water and improved access to safe
water, sanitation and hygiene (WASH) [36]. The impact of such an integrated approach has
been demonstrated in Egypt, where schistosomiasis is being tackled through targeted MDA
and WASH improvements [37]. The lack of integrated comprehensive approaches to reduce
both infection levels and transmission as well as the short-term timescale of MDA may explain
the challenge experienced by other counties for example, Kenya [24] and Uganda [38], in
improving the impact of MDA alone on infection levels/transmission. A comprehensive
national impact assessment exercise for the national control program as is planned by Zim-
babwe’s Ministry of Health at the end of this initial phase of the country’s helminth control
program will be informative in shaping the next stages in the country’s control of
schistosomiasis.
We designed the study sampling framework based on the results of the national control sur-
vey which formed the basis of Zimbabwe’s national control program [2]. Surveying all sentinel
sites at every survey point would have given more information, but the perceived benefit from
this did not justify the associated expense. In the national survey, 50 children per school were
sampled, whereas in this study, in the majority of schools we sampled at least 200 children.
Sample sizes lower than 200 were reflective of the enrolment numbers of children of the appro-
priate age group at the school. The follow-up of 75% of the children over the 6 years reflects
predominantly children who moved school to a different area and could not be traced. Chil-
dren remained eligible for follow-up if they moved to the local catchment area senior school
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i.e. within the same district and often served by the same river system to avoid following chil-
dren who moved to areas of different schistosome transmission dynamics.
The data were presented summarily at province level; however, as control efforts strengthen
in the move towards elimination, more refined mapping at district level, therefore more
schools, will be more informative. For infection diagnosis, we used the parasitological exami-
nation of urine and stool samples and this showed the reduction of egg counts to 0 for both
species of schistosome infections. Although the parasitological examination of urine and stool
is the currently recommend diagnostic for schistosomiasis, we and others have previously
shown that the approach is less sensitive when infection levels are low [27] and therefore more
accurate diagnostic tools are needed to monitor progress of control efforts. Alternative diag-
nostic approaches including PCR [39] and parasite antigens [40–43] have been used by others,
albeit not routinely in national MDA programs where there may be challenges with diagnostic
accuracy [44]. Although beyond the scope of this study, information on the transmission
dynamics in the local infective water bodies which the children frequented would have added
valuable information on the impact of treatment on the force of infection.
On a schistosome elimination agenda, there is need to extend treatment to cover the whole
community, including preschool aged children (aged 5 years and below) as well as adults.
Indeed the guidelines from WHO indicate that preventative chemotherapy should be targeted
at all groups at risk of infection in highly endemic communities [45]. Quantitative work has
shown that integrated community-wide treatment for schistosomiasis and soil-transmitted
helminths can be highly cost effective even in areas of low endemicity for either schistosomia-
sis or STH [46]. It is also important to be cognizant of the fact the current WHO guidelines
were not designed with the goal of elimination so current control strategies will need to be
adapted to deliver elimination while new or better tools for diagnosis and verification of cessa-
tion of transmission will need to be developed. Indeed, the WHO already acknowledges the
need for flexibility in control approaches for different counties in the roadmap for controlling
and eliminating NTDs [9]. Thus Zimbabwe’s approach of annual treatments regardless of the
schistosomiasis endemicity level at the operational region may have been more effective. Zim-
babwe’s last MDA was in 2017 and the country is now evaluating the impact of the control
program to inform the next steps in the country’s helminth control action plan.
In conclusion, based on the survey of schistosome infection and S. haematobium morbidity
in a cohort of school children in sentinel sites across the country, Zimbabwe’s helminth con-
trol program significantly reduced schistosome infection and morbidity levels in this cohort of
school-age children to levels where elimination is a possible goal. If extrapolated to national
level, the control program moved the country from a moderate to low endemicity levels as per
WHO classification for schistosomiasis [14]. The findings of this study will inform the design
of the country’s integrated control strategy towards elimination following a national assess-
ment of the impact of the national helminth control program at all previously surveyed sites.
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S1 Fig. The 35 sentinel sites chosen to represent districts (and thus provinces) in the coun-
try. The districts are colour coded to represent baseline schistosome infection prevalence clas-
sified into low infection (coloured grey), moderate infection (coloured blue) and heavy
infection (coloured red) and indicating the number of surveys conducted per sentinel site.
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N = Matabeleland North, Mat S = Matabeleland South.
(DOCX)
PLOS NEGLECTED TROPICAL DISEASES Efficacy of Zimbabwe’s schistosomiasis control program in a cohort of school children
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008388 June 22, 2020 19 / 23
S2 Fig. Combined prevalence of S. haematobium and S. mansoni in the cohort of Zimbabwean
school children (a) before year 2012, and (b) after year 2017 Mass Drug Administration with
Praziquantel. Maps were generated using the primary raw data and plotted using ArcMap
10.1.
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S3 Fig. Summary % coverage of schistosome treatment at provincial level in the school
children cohort in the last MDA in 2017.
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